Abstract
The purpose of this study was to describe the current use of statins in United States (US) veterans at W. G. Hefner Veterans Affairs Medical Center (VA Salisbury) with chronic hepatitis C virus (HCV) compared to those without chronic HCV and to examine why statin use may be avoided in this population. In this retrospective chart review, eligible participants were veterans enrolled in VA Salisbury primary care services who were at least 18 years of age with a diagnosis of dyslipidemia. Veterans must have had a lipid panel drawn between April 25, 2011 and October 25, 2011. The primary outcome of this study was to determine the prevalence of statin use among US veterans with HCV. A secondary outcome was to determine the proportion of subjects reaching goal LDL levels. A total of 157 subjects were included in this study. A significant difference in statin use was seen between subjects with and without HCV (54% vs. 83%, p <0.001). Although there were a greater number of subjects on statins in the non-HCV group, there was not a significant difference in the proportion of subjects reaching their LDL goal between the two groups. Among veterans, statins are used less frequently in patients with HCV compared to those without HCV. Both gr...Continue Reading
References
Aug 1, 1993·Journal of the American College of Cardiology·E D Frohlich
Dec 25, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason A DominitzKeith A Young
Jun 16, 2005·Current Opinion in Rheumatology·Manuel Ramos-Casals, Josep Font
Oct 29, 2005·The American Journal of Cardiology·Kimberly Gibson, Joseph P Rindone
Apr 4, 2006·The American Journal of Cardiology·James M McKenneyUNKNOWN National Lipid Association Statin Safety Assessment Task Force
May 16, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shirin KhorashadiRamsey C Cheung
May 17, 2006·Annals of Internal Medicine·Gregory L ArmstrongMiriam J Alter
Jun 5, 2007·Pharmacotherapy·Marisel Segarra-NewnhamEllen M Martin-Cooper
Aug 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·James H LewisUNKNOWN Pravastatin in Chronic Liver Disease Study Investigators
Jan 8, 2009·Journal of General Internal Medicine·Matthew S FreibergAmy C Justice
Apr 29, 2009·European Journal of Gastroenterology & Hepatology·Gowdara Divakara MurthySushma Venugopal
Oct 27, 2009·Trends in Endocrinology and Metabolism : TEM·Gulam H SyedAleem Siddiqui
Feb 4, 2010·Clinics in Liver Disease·Angela Michelin, David K Henderson
Dec 17, 2010·Circulation·Véronique L RogerUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 19, 2011·Current Opinion in Cardiology·Philippe J Zamor, Mark W Russo
Citations
Sep 21, 2006·BMC Complementary and Alternative Medicine·Della KwanHeather Boon
Sep 27, 2018·Nursing & Health Sciences·Shu-Mei TsaiYun-Fang Tsai
Apr 27, 2018·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·F R RolliA Cicchetti
May 31, 2019·Journal of Clinical Laboratory Analysis·Shuo YangLiyan Cui
Aug 16, 2017·The Kaohsiung Journal of Medical Sciences·Ching-I HuangWan-Long Chuang
Aug 7, 2017·Journal of the International AIDS Society·Jason GrebelyMarina B Klein
Dec 19, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jie WuLanjuan Li
May 10, 2018·Family Practice·William C W WongJason J Ong
Sep 19, 2019·Public Health Reports·Caroline M AbeAnk E Nijhawan
Nov 14, 2019·Transactions of the Royal Society of Tropical Medicine and Hygiene·Ahmed NagatyEkram W Abd El-Wahab
May 5, 2017·Food & Nutrition Research·Danielle GonçalvesThais Cesar
Jul 29, 2016·World Journal of Gastroenterology : WJG·Martin JanickoPeter Jarcuska